[Tumor hypoxia:advantage or disadvantage?].
Minn
Heikki
H
TYKS, Syöpätautien Klinikka, Turku. heikki.minn@utu.fi
Jaakkola
Panu
P
D045744:Cell Line, Tumor; D006801:Humans; D000860:Hypoxia; D009369:Neoplasms / Q000098:blood supply* / Q000628:therapy*; D011379:Prognosis; D016896:Treatment Outcome